BURNING ROCK BIOTECH LTD-ADR (BNR)
US12233L1070 - ADR
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 615.10M | 905.50M | 1.43B | 1.90B | 94.20M | |||
| Marketable Securities | N/A | 2.10M | 65.60M | 367.40M | 316.70M | |||
| Receivables | 149.61M | 170.20M | 157.90M | 147.10M | 208.50M | |||
| Inventories | 69.02M | 130.30M | 123.20M | 68.00M | 58.10M | |||
| Other Current Assets | 50.37M | 50.60M | 42.90M | 45.80M | 29.20M | |||
| Total Current Assets | 884.10M | 1.26B | 1.82B | 2.52B | 706.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 144.20M | 300.00M | 406.40M | 111.50M | 89.30M | |||
| Investments And Advances | 337.00K | 700.00K | 900.00K | 1.40M | 40.20M | |||
| Intangibles | 964.00K | 2.00M | 5.20M | 3.50M | 300.00K | |||
| Other Non-Current Assets | 5.09M | 20.90M | 45.10M | 23.00M | 11.00M | |||
| Total Non-Current Assets | 155.91M | 328.70M | 457.70M | 139.30M | 140.80M | |||
| TOTAL ASSETS | 1.04B | 1.59B | 2.28B | 2.66B | 847.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | N/A | 0.00 | 2.40M | 7.40M | 2.40M | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 39.50M | 42.00M | |||
| Accrued Expenses | 113.57M | 191.50M | 149.70M | 78.90M | 51.00M | |||
| Accounts Payable | 18.06M | 50.90M | 63.10M | 35.50M | 12.30M | |||
| Other Current Liabilities | 131.73M | 169.00M | 157.00M | 80.30M | 56.70M | |||
| Total Current Liabilities | 263.36M | 411.50M | 372.20M | 241.50M | 164.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | N/A | 0.00 | 0.00 | 0.00 | 23.10M | |||
| Other Non-Current Liabilities | 8.23M | 17.70M | 61.10M | 500.00K | 24.50M | |||
| Total Non-Current Liabilities | 8.23M | 17.60M | 61.10M | 500.00K | 47.60M | |||
| TOTAL LIABILITIES | 271.59M | 429.10M | 433.30M | 242.00M | 212.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -3.85B | -3.20B | -2.23B | -1.42B | -946.50M | |||
| Additional Paid In Capital | 4.85B | 4.58B | 4.28B | 4.01B | 45.60M | |||
| Common Shares | 137.00K | 100.00K | 100.00K | 100.00K | 1.53B | |||
| Treasury Stock | -65.90M | -58.90M | N/A | N/A | N/A | |||
| Other Shareholders' Equity | -161.53M | -165.70M | -207.10M | -167.60M | 9.30M | |||
| Shares Outstanding | 102.87M | 105.30M | 105.30M | 105.00M | 101.99M | |||
| Tangible Book Value per Share | 7.47 | 11.00 | 17.51 | 23.07 | -8.76 | |||
| Total Shareholders' Equity | 768.41M | 1.16B | 1.85B | 2.42B | 635.50M | |||
| TOTAL LIABILITIES AND EQUITY | 1.04B | 1.59B | 2.28B | 2.66B | 847.60M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.04 | |||
| Current Ratio | 3.36 | 3.06 | 4.89 | 10.45 | 4.30 | |||
| Return On Assets (ROA) | -62.85% | -61.18% | -34.96% | -17.72% | -39.43% | |||
| Return On Equity (ROE) | -85.07% | -83.85% | -43.17% | -19.49% | -52.59% | |||
All data in CNY